Cyr Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
1,379
+153
+12% +$156K 0.86% 15
2026
Q1
$1.13M Buy
1,226
+147
+14% +$149K 0.66% 33
2025
Q4
$1.16M Sell
1,079
-37
-3% -$35.4K 0.72% 26
2025
Q3
$852K Buy
1,116
+33
+3% +$24.6K 0.58% 37
2025
Q2
$844K Buy
1,083
+262
+32% +$204K 0.65% 36
2025
Q1
$678K Buy
821
+91
+12% +$75.7K 0.61% 30
2024
Q4
$564K Buy
+730
New +$604K 0.51% 39

Other funds holding LLY

Cyr Financial's LLY Position: Q2 2026 in Review

Cyr Financial increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $156K and bringing the position to 1,379 shares worth $1.65M. The position accounts for 0.86% of the portfolio, ranked #15.

Cyr Financial first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cyr Financial held 1,379 shares of Eli Lilly worth $1.65M as of Q2 2026.
  • Cyr Financial bought 153 Eli Lilly shares in Q2 2026, an estimated $156K.
  • Eli Lilly made up 0.86% of Cyr Financial's portfolio in Q2 2026, its #15 holding.
  • Cyr Financial first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cyr Financial's 13F filing for Q2 2026, filed 20 Jul 2026.